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Introduction: Electronic audit and feedback (e-A&F) systems are used worldwide for care quality improvement.
They measure health professionals’ performance against clinical guidelines, and some systems suggest im-
provement actions. However, little is known about optimal interface designs for e-A&F, in particular how to
present suggested actions for improvement. We developed a novel theory-informed system for primary care (the
Performance Improvement plaN GeneratoR; PINGR) that covers the four principal interface components: clinical
performance summaries; patient lists; detailed patient-level information; and suggested actions. As far as we are
aware, this is the ﬁrst report of an e-A&F system with all four interface components.
Objectives: (1) Use a combination of quantitative and qualitative methods to evaluate the usability of PINGR
with target end-users; (2) reﬁne existing design recommendations for e-A&F systems; (3) determine the im-
plications of these recommendations for patient safety.
Methods: We recruited seven primary care physicians to perform seven tasks with PINGR, during which we
measured on-screen behaviour and eye movements. Participants subsequently completed usability ques-
tionnaires, and were interviewed in-depth. Data were integrated to: gain a more complete understanding of
usability issues; enhance and explain each other’s ﬁndings; and triangulate results to increase validity.
Results: Participants committed a median of 10 errors (range 8–21) when using PINGR’s interface, and com-
pleted a median of ﬁve out of seven tasks (range 4–7). Errors violated six usability heuristics: clear response
options; perceptual grouping and data relationships; representational formats; unambiguous description; vi-
sually distinct screens for confusable items; and workﬂow integration. Eye movement analysis revealed the
integration of components largely supported eﬀective user workﬂow, although the modular design of clinical
performance summaries unnecessarily increased cognitive load. Interviews and questionnaires revealed PINGR
is user-friendly, and that improved information prioritisation could further promote useful user action.
Conclusions: Comparing our results with the wider usability literature we reﬁne a previously published set of
interface design recommendations for e-A&F. The implications for patient safety are signiﬁcant regarding: user
engagement; actionability; and information prioritisation. Our results also support adopting multi-method ap-
proaches in usability studies to maximise issue discovery and the credibility of ﬁndings.
1. Introduction
Quality measurement is central to improvement strategies [1]. It
identiﬁes where action is needed and monitors the eﬀects of improve-
ment eﬀorts [1]. In health care, this measurement is usually set in the
context of ‘audit and feedback’ (A&F) or ‘clinical performance feed-
back’, where compliance with clinical standards or patient outcomes is
the common metric [2]. Clinical performance is primarily fed back as
‘quality indicators’, ‘performance measures’, or similar quantities [2].
Electronic audit and feedback (e-A&F) systems communicate this in-
formation to health professionals mostly through interactive browser-
based portals or desktop applications [3]. They are in use throughout
the world, described variously as dashboards, benchmarking tools,
scorecards etc [3].
Core to e-A&F systems is the presentation of quality indicators,
which may be supplemented by the following components: patient lists;
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detailed patient-level information; and suggested actions [3]. Despite
the potential importance of these components for actionable data in-
terpretation [4], relatively little is known about designing usable in-
terfaces for e-A&F to optimise user interaction and reduce errors during
decision making [3]. In particular, existing evidence regarding e-A&F
usability has been limited to systems without key interface components
(e.g. suggested actions), and has largely ignored how interface design
can aﬀect user interaction when interpreting clinical performance data
[3]. Evidence from the health informatics literature demonstrates that
the design of information systems without regard for usability can in-
crease technology-induced errors [5]. In the case of e-A&F systems such
errors may have adverse consequences for patient safety by reducing
the system’s eﬀectiveness to improve health care outcomes [4].
Therefore poorly designed e-A&F interfaces may result in mis-
interpretation or ignorance of important information, which could ul-
timately lead to failings in care quality and eﬃciency (e.g. [6]).
We have previously reported a usability inspection evaluation of an
e-A&F system for primary care – the Performance Improvement plaN
GeneratoR; PINGR [3]. PINGR is currently unique among published e-
A&F systems in that it possesses all key interface components: clinical
performance summaries (i.e. quality indicators); patient lists; detailed
patient-level information; and suggested actions [3]. Its design employs
existing evidence and theory regarding eﬀective A&F, and is intended
to be generic so it can host quality indicators from a range of clinical
areas. Consequently, usability ﬁndings from PINGR provide valuable
insights into how to best design interfaces for e-A&F systems, and the
ﬁndings may generalise to other settings such as secondary care. The
results of PINGR’s usability inspection study enabled us to create a set
of generic interface design recommendations for e-A&F systems, cov-
ering each of their interface components and how they can be in-
tegrated [3]. The study also represented the ﬁrst step in an iterative
approach to optimise PINGR prior to deployment in routine clinical
practice [5,7].
The present study extends usability testing to target end-users
(primary care clinicians) as planned in PINGR’s development frame-
work [5]. We seek to understand how the interface helps or hinders user
interaction across a range of information interpretation and decision-
making scenarios in clinical quality improvement. To achieve this we
used a multi-method study design, collecting and analysing multiple
types of qualitative and quantitative data [8]. Multi-method studies
have been extensively used in both the natural and social sciences to
combine diﬀerent types of qualitative and quantitative data, such as
self-administered questionnaires, semi-structured interviews, and eth-
nographic observations [9]. Common uses for integrating these dif-
ferent data include but are not limited to: gaining a more comprehen-
sive account of the phenomenon of interest (completeness); augmenting
or building on each others’ results (enhancement); explaining ﬁndings
from another dataset (explanation); and corroborating or disconﬁrming
each others’ ﬁndings in order to increase validity (triangulation) [10].
Multi-method approaches are particularly suitable for usability studies
in clinical informatics given the increasing complexity of modern in-
formation systems [11]. They have been found to more comprehen-
sively uncover usability issues [12], and address diﬀerent aspects of
usability through triangulation and complementarity [13], than either
of their constituent methods alone. However, challenges remain with
regard to how to most eﬃciently and eﬀectively synthesise these dif-
ferent data sources [14]. Consequently, the originality of this work lies
in studying not only how primary care clinicians interact with e-A&F
systems, but also how laboratory-based multi-method usability eva-
luations may be conducted.
1.1. Aim and objectives
The aim was to understand, through usability testing with end-users
and theory-based abstraction, how the design of clinical e-A&F inter-
faces could facilitate improvements in patient safety.
The objectives were to:
1. test the usability of PINGR in terms of eﬃciency, errors, satisfaction,
and utility, using a multi-method approach, combining data from
observations of on-screen and visual search behaviour during task
performance, post-test user satisfaction questionnaires, and in-depth
interviews;
2. use these ﬁndings to extend and reﬁne our previous set of interface
design recommendations for e-A&F systems [3] in relation to their
main interface components (clinical performance summaries; pa-
tient lists; detailed patient-level information; and suggested actions),
whilst comparing them to the wider usability literature; and
3. determine the implications of these interface design recommenda-
tions for patient safety by drawing on evidence regarding clinical
audit and feedback implementation.
2. Materials and methods
2.1. The evaluated system: PINGR
PINGR is an e-A&F system for primary care professionals, developed
by the authors (Fig. 1): a primary care physician/informatician (BB), a
software engineer/informatician (RW), and a human-computer inter-
action expert (PB). PINGR is a web-based application that stands alone
outside clinical systems. It analyses structured data extracted from
electronic health records (EHRs) on a nightly basis against clinical
standards and patient outcomes (e.g. from clinical guidelines).
PINGR’s present interface design was informed by a usability in-
spection study [3], and an emerging theoretical causal model of eﬀec-
tive audit and feedback [15,16]. The use of theory is recommended in
the design of complex interventions in general [7], and of e-A&F tools
speciﬁcally [17]. Our approach is informed by an ongoing systematic
meta-synthesis of qualitative studies [15], and draws on: existing the-
ories (such as Control Theory [18] and Feedback Intervention Theory
[19]); intervention description frameworks (e.g. [20]); and organisa-
tional implementation models (e.g. [21]). The remainder of this section
presents a detailed account of the design and rationale of PINGR’s four
main interface components.
2.1.1. Clinical performance summaries
The PINGR interface (Fig. 1) employs the overview-preview prin-
ciple to display information at diﬀerent levels of detail based on
Shneiderman’s visual search mantra [22]. Presenting an overview of
clinical performance data with details on demand was found to be an
important usability feature in e-A&F systems [3]. The overview is
provided as performance summaries at the level of the primary care
practice/oﬃce (Fig. 1; top), where quality indicators are grouped into
separate data representation modules for each clinical area. This
module oriented design was employed to: enhance information pro-
cessing, as is usual practice with clinical guidelines [23]; and facilitate
user workﬂow [24]. Within each clinical area, quality indicators are
further grouped into common care pathways associated with long-term
care: diagnosis, monitoring and control [25], with an additional ex-
clusions pathway to track patients excluded from the quality standards
for clinical reasons (e.g. terminal illness). The purpose of the pathway
groupings is to create a framework for representing a variety of clinical
conditions consistently – as recommended in design best practice for
EHRs [26] and clinical decision support (CDS) systems [27].
Currently, PINGR supports four clinical areas: hypertension,
asthma, chronic kidney disease, and atrial ﬁbrillation (AF). These
clinical areas were chosen because they are:
1. managed mostly in primary care, making them familiar to end-users;
2. common components of multimorbidity – a major quality/safety
issue in primary care [28] and core to the challenge of summarising
patient information across multiple clinical areas [29], which is
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often not addressed by CDS systems [30];
3. often poorly cared for, resulting in serious adverse outcomes for
patients and ﬁnancial impacts on the health system (e.g. [31]), so
address a quality improvement need;
4. associated with diﬀerent quality indicators from diﬀerent guidelines
(e.g. process and outcome measures [25]; quality problems of
overuse and underuse [32]; competing recommendations), so are
suitable exemplars from which to generalise ﬁndings; and
Fig. 1. The Performance Improvement plaN GeneratoR. Overview level interface (top) displaying clinical performance summaries (light blue border boxes at the centre of the screen,
where each box represents a care pathway: diagnosis, monitoring, control and exclusions) and organisation-level suggested actions (light red border box, right-hand side of the screen).
Preview level interface (bottom) displaying the improvement opportunities bar chart, patient lists, detailed patient-level data and suggested actions. The background colour of the
detailed patient-level data interface component turns red when an improvement opportunity is present. AF= atrial ﬁbrillation; A/C= anticoagulation; BP= blood pressure;
DASH=Dietary Approaches to Stop Hypertension; NICE=National Institute for Health and Care Excellence; OD=Once daily; QOF=Quality and Outcomes Framework. (For in-
terpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 1. (continued)
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5. covered by other commonly used existing e-A&F systems, enabling
users to make comparisons with PINGR about its relative (dis)ad-
vantages.
As prescribed by cognitive ﬁt theory [33], quality indicators are
displayed as separate modules for tables and line graphs to support both
symbolic and spatial information processing respectively. Both involve
perceptual and analytical processes that are fundamental to the inter-
pretation and understanding of quantitative health information [34]. In
addition, providing users the option to select between tables and line
charts is in accordance with mainstream usability heuristics (e.g. [35]),
and eﬀective audit and feedback data presentation theories [4,36].
Tables are presented by default, which users can switch to display time
trends as line graphs. The rationale for displaying tables ﬁrst rather
than line graphs was that the addition of rows to tables would more
easily facilitate the expansion of PINGR to include further quality in-
dicators, whilst at the same time facilitating users to easily interpret
their current clinical performance [33]. Although many e-A&F systems
explicitly compare user’s quality indicator scores to targets/goals [3],
evidence for their use in improving feedback eﬀectiveness is mixed [2].
Therefore in accordance with actionable feedback design [37], PINGR
non-judgmentally presents clinical performance data to users which
they can compare with their past performance on line charts, and their
internal beliefs regarding care quality [19].
Using a menu on the left side of the screen, users can display per-
formance summaries for a speciﬁc clinical module at the overview level
(e.g. AF; Fig. 1; top), or proceed directly to the preview level to view
more detail by selecting a care pathway (i.e. diagnosis, control, treat-
ment or exclusion; Fig. 1; bottom). Users can also access the preview
level (Fig. 1; bottom) by selecting one of the pathway’s data re-
presentation modules in the overview interface (Fig. 1; top, blue co-
loured rectangular areas). At the preview level, information is pre-
sented regarding all patients who have not achieved the quality
indicator and for whom improvement opportunities have been identi-
ﬁed (Fig. 1; bottom, left side). For example, for hypertension control,
these are patients whose latest blood pressure in the past 12months is
above 139/89mmHg or above (or 149/89mmHg if they are> 79 years
old) based on national quality standards [38]. An interactive bar chart
shows the improvement opportunities identiﬁed for patients (Fig. 1;
bottom, left side above the list). By selecting a bar within the chart, the
user can generate a list of all patients in whom the improvement op-
portunity is relevant, for example, all patients currently prescribed
suboptimal medication, or those that may have medication adherence
issues. Each improvement opportunity is accompanied by an explana-
tion as to what it refers, and its eligibility criteria, communicated via
short static notes at the top of the patient list and tooltips. The use of
static notes and tooltips were found to be important for users to com-
plete the goal-action sequence of data interpretation tasks in the context
of e-A&F systems [3]. A user can switch from patients who have not
achieved the quality indicator (“patients with improvement opportu-
nities”), to those who have (“patients OK”) using the corresponding tabs
at the top of the bar chart. The user can also use a separate set of tabs to
select diﬀerent quality indicators relevant to the clinical pathway. For
example, in hypertension control there are diﬀerent blood pressure
targets recommended by diﬀerent organisations (e.g. [38,39]). For each
generated list of patients, users can view detailed patient-level data by
selecting a speciﬁc patient identiﬁcation number (Fig. 1; bottom, right-
hand side). Patient lists, detailed patient-level information and sug-
gested actions components of the PINGR interface are discussed in more
detail below.
2.1.2. Patient lists
As described above, patients achieving and not achieving each
quality indicator are listed in the preview interface for each care
pathway module (Fig. 1; bottom, left side). These lists can be ordered by
patient-level clinical variables to enable users to prioritise high-risk
patients, which may improve the eﬀectiveness of e-A&F [40]. For ex-
ample, patients with improvement opportunities in their hypertension
care can be ordered according to their last systolic blood pressure
reading. In addition, following PINGR’s usability inspection study [3]
the current version includes further variables such as patients’ identi-
ﬁcation number and their number of improvement opportunities. As
explained in Section 2.1.2, the lists of patients not achieving a quality
indicator can be ﬁltered by clicking the improvement opportunity bar
chart (Fig. 1; bottom, left side above the list), which displays the
number of patients in relevant categories (see Section 2.1.4 below for a
more detailed explanation of how these categories are derived). This
chart acts as an interactive visual query mechanism to list patients re-
quiring similar improvement tasks, thus minimising user cognitive load
by grouping together patients that require the same clinical action
[41,42]. Finally, an “All patients” list presents all patients within PINGR
across all quality indicators combined.
2.1.3. Detailed patient-level information
Detailed patient-level information can be displayed adjacent to
patient lists (Fig. 1; bottom, right side). Both patient lists and patient-
level information are displayed concurrently to facilitate user’s antici-
pated workﬂow of eﬃciently selecting new patients requiring im-
provement action [43]. Patients can be selected to display their in-
formation from the lists or via a search box at the top of the page. To
improve system status visibility [35] as suggested from our usability
inspection study, the patient-level information is separated from the
patient list by a border, and when a new patient is selected a self-
healing fade indicates their data is presented [3]. At the top of the
patient-level information component a dropdown menu provides access
to information relevant to each quality indicator. For example, selecting
the blood pressure control indicator displays patient’s blood pressure
measurements, whereas selecting the atrial ﬁbrillation anticoagulation
monitoring displays their International Normalised Ratio (INR) read-
ings. As recommended in our usability inspection study [3], these data
are by default presented using interactive line charts to help users assess
patient readings over time (e.g. tooltips display details in the x and y
axis for each data point), and are contextualised with relevant addi-
tional non-clinical details using tool-tips and vertical markers (e.g. re-
cent medication changes or face-to-face consultations). A toggle option
is available to alternatively present these data as tables [33]. Further
clinical information, including the patient’s current medications and
allergies, is presented below the line charts to improve interpretation of
data and suggested actions for each quality indicator (Fig. 1; bottom).
This design decision is also supported by research showing that addi-
tional clinical information can improve clinician decision-making [44]
and user experience [27]. As data in the e-A&F system may diﬀer from
those in the EHR [43], functionality is available for users to indicate
whether or not PINGR has correctly identiﬁed an improvement op-
portunity for a patient, and whether patient-level data is correct, using
agree (thumbs up) and disagree (thumbs down) icons.
In accordance with evidence from non-clinical dashboards [41] and
CDS systems [27], quality indicators listed in the dropdown menu are
colour-coded and prioritised: clinical areas in which the patient violates
a quality indicator are presented ﬁrst in red, those they have achieved
are second in green, and indicators that are not relevant to the patient
but are still within PINGR are at the bottom in grey. Colour is a reliable
pre-attentive property that facilitates quick identiﬁcation of informa-
tion without sequential searching, which can reduce short-term
memory load [45,46]. The use of colour was identiﬁed as an important
element for the unobstructive completion of tasks in the cognitive
walkthrough evaluation of an earlier version of PINGR [3]. The purpose
of presenting data related to achieved and irrelevant indicators is to
enable users to highlight if PINGR incorrectly classiﬁes a patient (false
negatives), in order to improve its algorithms [47] and support error
prevention [27].
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2.1.4. Suggested actions
The deﬁning feature of PINGR is that it suggests care quality im-
provement actions that users could take (a feature usually seen in point-
of-care CDS not e-A&F systems [16]), which we call ‘decision-supported
feedback’ [3,16]. PINGR provides two types of suggested actions to
users based on their speciﬁc clinical performance [48,49]: organisation-
level and patient-level. This is because: evidence suggests that both
types are required for eﬀective improvement action [50]; health pro-
fessionals have diﬃculty and limited time to develop their own im-
provement actions [40]; and providing suggested actions alongside
feedback is shown to improve its eﬀectiveness [2]. Organisation-level
suggested actions relate to steps that the primary care practice/oﬃce
team could take collectively to improve, such as introducing a new
service or changing the way they work. In the PINGR interface these are
presented at the overview level, on the same page as the clinical per-
formance summaries showing quality indicators across the four path-
ways (diagnosis, monitoring, control, and exclusions), and relate to
suggestions for the whole clinical area (e.g. hypertension; Fig. 1; top,
right side). Patient-level suggested actions relate to changes clinicians
could make in caring for individual patients, such as introducing new
medication, or providing lifestyle advice. They are presented alongside
the detailed patient-level information component, with diﬀerent sug-
gested actions for each quality indicator accessed via the dropdown
menu (Fig. 1; bottom, right side). Organisation and patient-level sug-
gested actions are positioned to the right-hand side of the overview and
preview interface respectively to match the anticipated user workﬂow
of data interpretation and action according to both Control Theory
[18], CDS design guidelines [51] and ﬁndings from our usability in-
spection study [3]. Furthermore, this complies with CDS design re-
commendations for providing relevant patient data alongside alerts
[51,52].
We have previously published an early version of our methodology
for deriving patient-level suggested actions [31]. In brief, this involves
translating relevant clinical guidelines into rule-based algorithms to
analyse the EHR data for each patient that has not achieved the quality
indicator [31]. For example, in hypertension control one suggested
action concerns medication optimisation: data are analysed to derive an
up-to-date medication list, which is then compared with published
maximal doses [53] and clinical pathways [38]. If a patient’s current
medication dose is sub-maximal, then PINGR suggests increasing the
dose. Similarly, if their medication does not match the prescribed
clinical pathway, then PINGR suggests starting the most appropriate
medication. The algorithms also take into account contextual in-
formation about patients [51], such as relevant comorbidities and al-
lergies, by not suggesting medications for which they have a contra-
indication (e.g. PINGR would not suggest a beta blocker for a patient
with asthma). These patient-level actions form the basis of the cate-
gories in the improvement opportunity bar chart (Fig. 1; bottom). In
this version of PINGR, organisation-level actions were derived from
quality improvement actions in the wider literature and clinical
guidelines (e.g. [54]).
To improve help and documentation [3,55], information buttons
provide explanations for how suggested actions were generated. Hy-
perlinks to case reports of how other organisations had achieved change
and other useful clinical tools (e.g. patient information leaﬂets) are also
provided. These were designed to make the suggestions more action-
able by providing further information on demand [51], and drawing on
Social Proof Theory [56]. Users can agree or disagree with PINGR’s
suggested actions by clicking thumbs up or thumbs down icons re-
spectively. When the thumbs up icon is clicked, the action is saved to a
separate (“agreed actions”) page where it can be viewed, downloaded
to share with colleagues, and marked as “implemented”. When the
thumbs down icon is clicked users are asked why they disagreed with
the action, using optional ﬁxed and free-text responses [26,51]. As
guided by CDS literature this is intended to communicate that the re-
commendations are advisory, in order to improve system acceptability
and potentially system eﬀectiveness [51,57], in addition to collecting
information on how PINGR’s algorithms could be improved [47]. Users
can also add their own actions in addition to the ones suggested by
PINGR, which is intended to increase user control and freedom [35],
and build a user-sourced bank of suggestions.
Additional functionality suggested by PINGR’s usability inspection
study [3] included: use of consistent and concise statements to avoid
misinterpretation (all suggested action statements were written by BB
and pilot-tested with two additional clinicians); improved visibility of
system status (e.g. by showing clearly when a speciﬁc action was agreed
by turning green, disagreed by turning red and disappearing, or im-
plemented by using strikethrough text); prevention of errors by dis-
abling further editing of an action once marked implemented; sup-
porting user control over actions that have been agreed, disagreed or
implemented (including user-generated actions) by enabling undo/redo
and edit capabilities; and presentation of all suggested actions in a
consistent manner, using the same typographic features and layout
characteristics.
2.2. Participants and setting
To evaluate PINGR’s usability we recruited a sample of primary care
physicians (our intended end-user group) to interact with its interface
whilst performing a set of tasks. We used purposeful sampling [58] to
approach physicians that would typically be expected to use PINGR in
the real world through professional networks of lead author BB. A re-
quest was made either by phone, email or face-to-face to participate in a
study about the evaluation of a novel web-based e-A&F system aimed at
improving the quality of primary care. Physicians were eligible if they
regularly used: web applications on laptop or desktop computers; EHRs;
clinical decision support systems; and e-A&F systems. Eligibility was
determined using a short screening questionnaire (Appendix A), which
was sent via email along with an information sheet about the study. A
good level of familiarity was determined in terms of number of years in
practice (at least three years as primary care physicians), frequency of
computer and internet use (at least ﬁve to 10 h per week), and use of
specialised health care software at work (at least half the days).
Participant recruitment was conducted concurrently with data col-
lection and analysis. Our target sample size was between ﬁve to ten
participants to balance costs and maximise usability issue discovery
[59,60]. We stopped recruitment when thematic saturation was
reached, which we deﬁned as no new usability issues arising after two
further participants [61]. Applying this criterion, seven physicians in
total were approached and recruited to participate in the study (the
sample’s characteristics are presented in Section 3.1).
Testing took place at the usability laboratory of the School of
Computer Science of the University of Manchester, and was conducted
by author BB. At the beginning of each test participants were briefed
about the study objectives and usability test protocol, then asked to sign
a consent form. During brieﬁng participants were given a short stan-
dardised description of PINGR’s functionality, though no demonstration
or training was provided. Participants then completed two background
questionnaires measuring their level of graphical literacy [62] and
numeracy skills [63] as both characteristics could inﬂuence partici-
pants’ interaction with PINGR and therefore help understand any dif-
ferences in user interaction. PINGR was accessed via Google Chrome
browser on a desktop Windows computer with a 17-in. screen. For in-
formation privacy reasons the version of PINGR used in the tests used
only simulated patient data. Participants were oﬀered re-imbursement
for their time (£50) plus associated travel costs. The study was ap-
proved by the UK National Research Ethics Service (Harrow; reference
15/LO/1394) and Greater Manchester Clinical Research Network (re-
ference 187283).
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2.3. Tasks and task administration
Participants completed 7 tasks using PINGR (Appendix B) in a
within-subjects design. As shown in Table 1, tasks were designed to
assess participants’ interaction with all interface components of PINGR
using realistic actions users would perform with an e-A&F system based
on existing literature [15]. Speciﬁcally, tasks reﬂected both behavioural
and cognitive aspects of user interaction with the interface. To under-
stand the eﬀect of interface design on participants’ cognition, Tasks 1,
2, 3 and 5 required multiple perceptual and cognitive sub-tasks in-
cluding data interpretation (at both the organisational and patient-le-
vels), and judgment of the appropriateness of PINGR’s suggested ac-
tions. Tasks 4, 6 and 7 were focused on exposing behavioural aspects of
user interaction, such as locating speciﬁc information on the screen,
entering data and creating and downloading user-generated actions.
Tasks were presented in a randomised sequence (using the sample
command in R [64]) to mitigate the eﬀects of learning transfer, except
for Tasks 6 and 7, which for logical reasons were always last. Each task
was presented on-screen with contextual background information about
a ﬁctional primary care practice/oﬃce, and a patient as necessary,
which participants used to inform their judgments during the tasks. To
test the process of participants disagreeing with PINGR’s suggested
actions and patient-level data, some were phrased to purposefully
violate good clinical practice (e.g. suggesting a medication to which the
patient was allergic, or presenting inaccurate patient information). To
minimise participants acting unnaturally because they felt judged on
their performance using the software [65], it was made clear that it was
PINGR (not they) who were under evaluation.
2.4. Data collection
We measured usability in terms of eﬃciency (the time taken for
participants to complete each task); errors (task completion rate, and
the type and number of errors made); and user satisfaction with the
interface design [66]. In addition, we used utility as a fourth outcome
[66] based on the number of suggested actions agreed and disagreed
with while performing the tasks, and participants’ responses during
interviews. Data were collected using a multi-method approach, in-
cluding observation of user on-screen and visual search behaviour, post-
test satisfaction questionnaires, and in-depth debrieﬁng interviews.
2.4.1. User observation
We used Tobii Pro Studio with a Tobii T60 eye tacker to record
participants’ on-screen behaviour, eye movements, and time taken for
completion of speciﬁc tasks. The Tobii T60 eye tracker permits a 60-Hz
sampling rate, 0.5 degrees gaze point accuracy, and free head motion,
which was recalibrated before each task. Author BB observed con-
currently using a second monitor and took ﬁeld notes, which permitted
identiﬁcation of interesting aspects of user interaction that were dis-
cussed during debrieﬁng interviews.
2.4.2. Post-test questionnaires
Following task completion, participants completed two usability
questionnaires. We were unaware of any questionnaires speciﬁc to e-
A&F systems, and therefore used the System Usability Scale (SUS) [67],
and developed a questionnaire based on Shneiderman’s Object-Action
Interface model (Appendix C). The SUS is a validated questionnaire that
measures users’ overall satisfaction with a system’s interface [67]. It is
interface agnostic and consists of 10 items with total scores ranging
between zero and 100 [68]. Our Object-Action Interface questionnaire
consisted of two parts aimed at evaluating speciﬁc aspects of PINGR’s
user interface design: the ﬁrst contained seven items regarding the ease
or diﬃculty participants experienced undertaking actions during tasks;
the second contained eight items assessing the clarity of PINGR’s in-
terface objects (e.g. presentation of data or use of colour and termi-
nology). Both parts used a Likert scale from 1 to 5, with 1 representing
diﬃcult or unclear, and 5 indicating easy or clear.
2.4.3. In-depth debrieﬁng interviews
Finally, participants were interviewed about their experience using
PINGR after completing the questionnaires. Interviews were semi-
structured (Box 1), and focused on the strengths, weaknesses, oppor-
tunities for improvement, and threats of using the software (SWOT).
Questions explored concepts from Normalisation Process Theory (co-
herence, reﬂexive monitoring, cognitive participation, and collective
action), which seeks to understand the work that people do, in-
dividually and collectively, surrounding a particular practice (e.g. using
PINGR) rather than simply their beliefs or attitudes [69]. Other ques-
tions explored problems encountered during completion of tasks, ne-
gative responses to questions in the post-test questionnaires or other
relevant additional topics that arose during interviews. As necessary,
participants were replayed sections of their recorded on-screen inter-
action to clarify issues, and encouraged to further explore the PINGR
interface. Interviews ended when both the interviewee and interviewer
agreed all important topics had been covered. Interviews were audio-
recorded and transcribed verbatim, and all participants were oﬀered
the option of reviewing their transcripts prior to analysis. Field notes
were kept throughout the process.
Table 1
Overview of tasks performed by participants.
# Description Interface components assessed Evaluated aspects of human cognition/behaviour
1 Interpret feedback and organisation-level actions across multiple
quality indicators
Clinical performance summary
Suggested actions
Identiﬁcation and interpretation of relevant clinical performance
summary
Judgment of organisation-level suggested actions
2 Interpret feedback and patient-level actions regarding a single
quality indicator
Clinical performance summary
Patient lists
Detailed patient-level information
Suggested actions
Identiﬁcation of relevant patient list
Identiﬁcation of appropriate patient from list
Interpretation of detailed patient-level information (single
disease)
Judgment of patient-level suggested actions (single disease)
3 Interpret feedback and patient-level actions regarding an individual
patient
Detailed patient-level information
Suggested actions
Identiﬁcation of relevant patient
Interpretation of detailed patient-level information (multiple
diseases)
Judgment of patient-level suggested actions (multiple diseases)
4 Add a user-generated suggested action Clinical performance summary
Suggested actions
Identiﬁcation of relevant suggested action area
Data input
5 Identify the patient with the most improvement opportunities Patient lists
Detailed patient-level information
Identiﬁcation of relevant patient list
Identiﬁcation of appropriate patient from list
6 Download saved actions Suggested actions Identiﬁcation of saved actions download function
7 Indicate an action plan has been implemented Suggested actions Identiﬁcation of implemented actions function
B. Brown et al. Journal of Biomedical Informatics 77 (2018) 62–80
67
2.5. Data analysis
Data analysis was concurrent with data collection. This enabled
exploration of important emerging concepts in later interviews [70],
and to recognise when thematic saturation had been reached [61]. Data
were integrated from screen recordings, eye movements, questionnaire
responses, interview transcriptions and ﬁeld notes, in order to identify
usability issues with PINGR in relation to its main interface compo-
nents. The rationale for this approach was to: gain a more complete
account of users’ interactions with PINGR; enhance and explain the
ﬁndings of each constituent method; and triangulate their results to
increase validity [10].
Fig. 2 shows a summary of the data collection and analysis process
with respect to the concepts they primarily measured (i.e. eﬃciency,
errors, satisfaction, and utility). However, often data sources were used
to illuminate ﬁndings beyond these primary measures e.g. interview
ﬁndings often provided insights into errors observed during user ob-
servation. To mitigate our results portraying an overly positive view of
PINGR [71], our emerging analysis was critically reviewed by and
agreed between our entire multidisciplinary research team (i.e. BB –
primary care physician and health informatics researcher, PB – human-
computer interaction expert, RW – software engineer, MS – statistician,
and IB – clinical and public health informatician). This encouraged
reﬂexivity, and increased credibility of our ﬁndings [72]. We used
medians rather than means as our measure of central tendency given
the small sample size and presence of outliers [73].
2.5.1. User observation
Videos of participants’ interaction with PINGR (i.e. on-screen ac-
tivity and visual search behaviour) were imported into NVivo 11 (QSR
International) for analysis with respect to eﬃciency, errors, and utility
[66]. Eﬃciency was calculated as the time taken for participants to
complete each task. Errors were deﬁned as deviations of actual from
expected user behaviour. A thematic content analysis [74] determined
the number and type of errors by categorising them according to CDS
system usability design heuristics [27], and the interface component to
which they related. We calculated the total number of errors performed
by users during each task, in addition to each task’s completion success
rate. Utility was calculated as the number of suggested actions users
agreed and disagreed with. Eye movement data in error-prone tasks
were analysed in Tobii Pro Studio to understand the attention paid to
areas of interest (AoIs). We deﬁned six AoIs according to the key in-
terface components of e-A&F systems; two at the overview level (Fig. 1;
top; clinical performance summaries, and organisation-level suggested
actions), and four at the preview level (Fig. 1; bottom; improvement
opportunities bar chart, patient lists, detailed patient-level information,
and patient-level suggested actions). We used heatmaps to visualise the
number and duration of ﬁxations on the interface, and collapsed ﬁxa-
tion sequences to understand how participants transitioned between
AoIs. Transition matrices presented the probability of participants
transitioning a ﬁxation from one AoI to another [75]. Because the tasks
used in this study included both reading and visual searching a ﬁxation
was deﬁned as a stable gaze lasting at least 100ms [76]. Any ﬁxation
lasting less than 100ms was recorded as a saccade, i.e. a rapid eye
movement between two ﬁxations where no new information is pro-
cessed by the participant [76]. When interpreted in conjunction with
the eﬃciency, errors and utility data, heatmaps and transition matrices
provided insights into participants’ workﬂow pattern and the appro-
priateness of how PINGR’s interface components were organised.
2.5.2. Post-test questionnaires
Data from post-test questionnaires were analysed in R [64]. Statis-
tics included median, range, and upper and lower quartiles.
2.5.3. In-depth debrieﬁng interviews
Interview transcripts and ﬁeld notes kept during the interviews
were imported into NVivo 11 (QSR International) for thematic content
analysis [74]. Data items were coded line-by-line by author BB to create
Box 1
Interview schedule.
Concepts from Normalisation Process Theory [69] addressed by each question explored in square brackets.
Opening question: How did you ﬁnd using PINGR?
Strengths.
• What are the advantages of PINGR? [Coherence]
• How useful or valuable do you think it would be in your primary care practice/oﬃce? [Cognitive participation]
• What, if anything, does it oﬀer over existing systems you use? [Coherence]
Weaknesses.
• What are the weaknesses of PINGR? [Coherence]
• What would be the disadvantages of using it in your practice/oﬃce? [Reﬂexive monitoring]
Opportunities.
• How do you think you would use PINGR in your practice/oﬃce? [Collective action]
• How could it be improved in order to become a routine part of patient care processes? [Reﬂexive monitoring]
• How does PINGR diﬀer from audit systems you currently use? [Coherence]
Threats.
• What are the potential threats to PINGR not being used in practice/oﬃce? [Cognitive participation/collective action]
• What problems may arise with it being used? [Cognitive participation/collective action]
• How does PINGR align with the goals of your practice/oﬃce? [Coherence]
Closing question: What have we missed that you think we should also discuss regarding PINGR?
B. Brown et al. Journal of Biomedical Informatics 77 (2018) 62–80
68
a set of themes that explained user perceptions of the PINGR tool. These
themes were organised into a framework based on the SWOT analysis at
the highest level, with lower level codes relating to PINGR’s four in-
terface components, NPT constructs, and usability heuristics [27]. The
process was iterative in that each data item was reviewed multiple
times to reﬁne themes and codes. Findings were discussed with and
critically reviewed by PB [72]; any disagreements were resolved
through discussion.
3. Results
3.1. Participants
Tests took place during September and October 2015, and took
between 1.5 and 2 h per participant. Each participant (2 female, 5 male;
age range 25–64 years) had between 6 and 33 years’ experience as a
medical doctor, 3 and 28 years’ experience as a primary care physician,
and 5 and 25 years’ experience undertaking audit and feedback. All
participants used EHRs and CDS systems daily at work, felt at least 70%
conﬁdent in their numeracy skills (e.g. using fractions, percentages, and
graphs) [63], and scored at least 85% on the graphical literacy test
[62]. All participants used e-A&F systems, though less often than EHRs
and CDS systems: one participant used them “nearly every day”, with
the rest using them “half the days” (n= 3) and “less than half the days”
(n= 3). None of the participants had used PINGR previously, or had
visual impairments that would aﬀect the quality of eye movement re-
cordings.
3.2. Eﬃciency
Fig. 3 shows the distribution of time spent by participants on each
task. Tasks 1–3 (1. interpret organisation-level feedback/actions; 2.
interpret patient-level feedback/actions – single indicator; and 3. in-
terpret patient-level feedback/actions – multiple indicators) were the
most time consuming, which could be because they were the most
complex. Although Task 5 (identify high-priority patient) also required
multiple perceptual and cognitive sub-tasks, these were limited to a
single data variable (number of improvement opportunities).
Conversely, Tasks 1–3 required interpretation and judgment of data
relating to either organisation-level performance or patient-level clin-
ical variables, both of which are multi-dimensional, in addition to their
corresponding suggested actions. Task 2 had the highest median com-
pletion time overall (4.5 min), though one participant during Task 1
spent the longest time across all tasks (11.7 min).
3.3. Errors
Participants committed a median of 10 errors (range 8–21) asso-
ciated with PINGR’s key interface components during all tasks, and
completed a median of 5 out of 7 tasks (range 4–7). Fig. 4 shows the
error frequency distribution for participants during tasks: it mirrors the
task duration distribution (Fig. 3) in as much as Tasks 1–3 (1. interpret
organisation-level feedback/actions; 2. interpret patient-level feedback/ac-
tions – single indicator; and 3. interpret patient-level feedback/actions –
multiple indicators) were associated with the most errors. These tasks
also had the lowest completion rates: Task 3 was lowest (1 participant
completed), followed by Task 2 (2 participants), and Task 1 (5 parti-
cipants); all participants completed tasks 4–7.
Fig. 5 shows the usability heuristic each error violated, and which
interface component it concerned. Six (16%) out of a possible 38
heuristic categories were violated [27]. The most frequently violated
was workﬂow integration (n=40), all of whose errors concerned the
detailed patient-level information (n=24) and suggested actions
(n= 16) interface components. With respect to detailed patient-level
information, participants (n=4) did not interact with thumb icons to
indicate whether PINGR had correctly identiﬁed an improvement op-
portunity, or whether the information presented was accurate. They
explained during interviews they would not have time to check these
during their busy clinical schedules. With respect to suggested actions,
participants (n= 5) did not indicate agreement with those they added
themselves: they felt this should be automatic to save time – although
they may disagree with an action to demonstrate it had been con-
sidered, the default would be agreement.
Other important errors related to: unclear response options when
undoing a prior action (dis)agreement or marking an action im-
plemented (n= 9); problems with perceptual grouping and data
Fig. 2. Summary of the data collection and analysis process. NPT=Normalisation Process theory, SWOT=Strengths, Weaknesses, Opportunities, Threats.
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relationships caused by the dropdown menu when accessing detailed
patient-level information (n= 8); visually indistinct screens for con-
fusable items when a new patient was displayed (n=6); and diﬃcul-
ties interpreting line charts as representational formats for one-oﬀ or
low readings of physiological parameters (n= 1).
Eye movement data analysis focused on Tasks 1–3 (1. interpret or-
ganisation-level feedback/actions; 2. interpret patient-level feedback/
actions – single indicator; and 3. interpret patient-level feedback/ac-
tions – multiple indicators) given they were the most time-consuming
and error-prone. An example is illustrated in the heatmap for Task 2
(Fig. 6), which is similar to that observed for Task 3. Both tasks required
identiﬁcation of appropriate patient-level information and suggested
actions at the preview page, which should result in greater visual ac-
tivity at those interface components. However, the heatmaps demon-
strated the opposite: a greater number of ﬁxations on the overview page
(Fig. 6). In addition, although the transition matrix of eye movement
sequences for Task 2 (Fig. 7) showed high probabilities of transitions
between AoIs compatible with optimal workﬂows for task completion,
it also demonstrated unexpected transitions – particularly at the over-
view page. When considered together, Figs. 6 and 7 suggest that al-
though integration of AoIs at the preview level (Fig. 1; bottom) largely
supported eﬀective user interaction, the overview level (Fig. 1; top)
unnecessarily increased user’s cognitive load. Typical errors at the
overview page relevant to Tasks 2 and 3 included participants selecting
the wrong quality indicator, which led to the wrong patient list, and
ultimately the wrong patient. These violated the unambiguous de-
scription heuristic and accounted for errors at the clinical performance
summary (n=12) and patient list interface components (n=11).
Participants (n=5) explained such errors arose because PINGR used
separate modules and pathways to organise quality indicators, making
it diﬃcult to prioritise on which one to focus. Although users could
view all quality indicators within the same clinical area concurrently,
they could not view indicators across diﬀerent clinical areas. Therefore,
judging which one required the most urgent attention required acces-
sing each module individually and comparing performance across dif-
ferent pathways. These problems were exacerbated because scores were
not explicitly compared to desirable levels of performance (targets/
goals), so making value judgments required further information pro-
cessing. Participants suggested comparisons with other primary care
practices/oﬃces would be most helpful in interpreting their perfor-
mance (peer benchmarking).
3.4. Satisfaction
The median SUS score was 73 (range 58–88), indicating a passable
level of satisfaction with PINGR’s usability [68]. This was supported by
interviews, where all participants (n=7) volunteered that PINGR was
easy to use. Nevertheless, some felt a tutorial module would be helpful,
particularly to highlight PINGR’s novel features such as its suggested
actions. Despite the number of errors observed, Fig. 8 shows that
overall participants felt tasks were easy to complete: the lowest median
Likert diﬃculty rating for any task was 3, and no participant gave the
lowest score of 1. Task 2 (interpret patient-level feedback/actions – single
indicator) was reported the most diﬃcult (median Likert rating=3,
range=3–4), with Tasks 1 and 3 (1. interpret organisation-level feed-
back/actions; and 3. interpret patient-level feedback/actions – multiple in-
dicators) joint second (median Likert ratings= 4, and ranges= 2–5).
This mirrors ﬁndings regarding eﬃciency and errors described above
(3.2 and 3.3, respectively). Participants who committed the most errors
in Tasks 1, 3 and 5 (identify high-priority patient) rated them as most
diﬃcult.
Fig. 8 also shows that participants felt in general that PINGR’s in-
terface was clear, with only one participant giving the lowest Likert
rating of 1 because they felt the font was too small. The patient lists
interface component was considered least clear (median Likert
rating= 3, range= 2–5): participants (n=3) wanted further clinical
variables to prioritise patients despite the additions made following
PINGR’s previous evaluation described in Section 2.1.3 above [3].
Suggestions included: patients’ age, as younger patients would likely
gain most beneﬁt from clinical actions; risk of a relevant outcome (e.g.
cardiovascular disease event in the blood pressure control quality in-
dicators); and whether patients had violated a particularly high risk
quality indicator (e.g. inappropriately untreated AF). Three participants
stated the number of patients in each list was overwhelming, and that in
practice they would likely not have the time or resources to review each
one. They would deal with this by focusing on the most high priority
patients, and by sharing lists with other staﬀ (e.g. printing lists for a
nurse to examine on their behalf). A further problem related to the use
Fig. 3. Time taken to complete each task by parti-
cipants. Each cross represents one participant.
Fig. 4. Number of errors made during each task by
participants. The size of the dot represents the number
of participants who committed that number of errors.
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of red ﬂag icons to denote the number of improvement opportunities.
This was confusing because in clinical medicine red ﬂags usually refer
to important clinical signs and symptoms. As an alternative they sug-
gested using a diﬀerent colour or icon (e.g. a lightbulb, star or light-
ening ﬂash).
Despite being associated with the most errors during tasks, the de-
tailed patient-level interface component was rated most clear by par-
ticipants (median Likert rating=5, range 2–5), with all but one par-
ticipant giving the highest score of 5. During interviews, participants
(n=3) made positive comments about the beneﬁts of visualising pa-
tients’ physiological data as line charts as it helped interpret its clinical
signiﬁcance, and prioritisation of patients.
Both the clinical performance summaries and suggested actions
interface components received a median Likert rating of 4. With respect
to clinical performance summaries, participants stated framing them
positively rather than negatively was preferable because it rewarded
clinicians and encouraged further action (e.g. showing the number of
correctly treated AF patients, rather than the number incorrectly
treated). They also suggested presenting the historic clinical
performance trend data alongside the current performance as default to
aid interpretation and quality indicator prioritisation, as it was unclear
how to access it via the toggle buttons. Similar suggestions were also
made regarding the improvement opportunities bar chart.
With regards to suggested actions, all participants stated they were
acceptable because they were presented as suggestions (rather than
diktats) and could be disagreed with. The majority (n= 4) were con-
cerned they would not have the time or resources to evaluate and im-
plement every suggested action, and would only be able focus on the
most important. However, they felt this would be diﬃcult because the
modular format of the clinical performance summaries prevented
viewing organisation-level actions across multiple quality indicators
concurrently, as did the dropdown menu in the detailed patient-level
information component for patient-level suggested actions. Participants
stated they only wanted to be presented with the top three or four most
important improvement actions they could implement, and that ideally
PINGR should make this judgment for them. They suggested actions’
importance could be ranked according to: clinical safety (e.g. high-risk
drug-drug interactions requiring urgent attention); potential
Fig. 5. Number of errors according to usability
heuristics [27] and interface component. *
“Unambiguous description” category was derived
by combining “unambiguous units” and “concise
and unambiguous language” [27].
Fig. 6. Visual attention heatmap for Task 2 (interpret patient-level feedback/actions – single indicator). Overview page is left; preview page is right. Red represents more ﬁxations
whereas orange, yellow and green progressively less. In this task users were asked to: select a speciﬁc quality indicator on the overview page to take them to the preview page; then at the
preview page select a patient from the list, and interpret the patient data and suggested actions. Consequently, more ﬁxations would be expected on the preview page (right) because the
majority of the task requires activity here, however, there are more ﬁxations on the overview page (left). (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
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eﬀectiveness (e.g. predicted impacts on patient outcomes); ﬁnancial
value (e.g. how much money the organisation could save from un-
necessary laboratory tests); and quick wins (i.e. the perceived ratio of
implementation eﬀort to potential beneﬁt – either clinical or ﬁnancial).
Almost all participants (n= 5) stated positioning suggested actions on
the right of the page was satisfactory as it mirrored their workﬂow of
data interpretation then action plan formulation. However, one parti-
cipant failed to complete a task because they did not visualise them. In
the same vein, participants recommended moving the “agreed actions”
page (where their agreed actions were saved) to the end of the navi-
gation menu to ﬁt with to ﬁt their workﬂow of reviewing action plans
last. Other recommendations for improving suggested actions included:
using less prose; providing detail on demand only; and including more
speciﬁc reasoning as to why each action was suggested.
3.5. Utility
During tasks, each participant viewed a median of 12 suggested
Fig. 7. Transition matrix of eye movement sequences between areas of interest during Task 2 (interpret patient-level feedback/actions – single indicator). Number of visual
transitions from one AoI to another as a proportion of transitions to all other AoIs. In this task users were asked to: select a speciﬁc quality indicator (clinical performance summary);
select a patient from the list (patient list); interpret the patient data (detailed patient-level information) and suggested actions (suggested actions – patient-level). Consequently, high
proportions of transitions would be expected between these AoIs to mirror the task completion sequence. However, there are also high proportions of transitions between AoIs not in the
sequence e.g. from ‘Clinical performance summary’ to ‘Suggested actions – organisational level’, and vice versa. The axis labels are ordered based on how they would be encountered
during the task. AoI=Area of Interest.
Fig. 8. Participant responses to the Object-Action Interface questionnaire. Actions are left; Objects are right. The size of the dot represents the number of participants who provided
that response.
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actions (range 5–13), of which they agreed with a median of 7 (range
4–8), disagreed with a median of 3 (range 0–6), and did not respond to
a median of 0 (range 0–8). Reasons for disagreements with organisa-
tion-level suggested actions were: prior implementation in the partici-
pant’s organisation (n= 4); a lack of implementation resources (n=1);
or a perceived ineﬃcient use of resources (n=1). Reasons for dis-
agreements with patient-level suggested actions related to: disagree-
ment with a clinical guidelines’ recommendation (n= 3); absence of
local services to carry out the suggestion (n=2); lack of information
regarding patients’ medication adherence (n= 1); and desire to clini-
cally assess the patient (n=1). Two participants did not respond to
suggested actions because they wanted to defer a decision following
either discussion with colleagues (regarding organisation-level actions)
or individual patients (for patient-level actions), or perform other ac-
tions ﬁrst. They suggested the ability to manually order and prioritise
actions in the “agreed actions” page, with functionality to assign actions
to other staﬀ members with deadlines and reminders to track progress,
may help with this issue and integrate PINGR with their workﬂows.
Worryingly, two participants agreed with patient-level actions for
which the patient had contraindications (i.e. patient refusal of a home
blood pressure monitoring service, and prescription of a medication to
which there was an allergy); on further questioning, both did not expect
the system to suggest actions to which there were documented reasons
against. Of their own accord, three participants added 10 actions to
PINGR they had formulated themselves. These covered organisation-
level actions (n= 2), such as services or quality improvement ideas not
currently suggested by PINGR, and patient-level actions (n= 8) re-
lating to lifestyle advice and medication safety issues. A summary of
ﬁndings relating to PINGR’s utility from the NPT-driven SWOT analysis
interviews is presented in Box 2.
4. Discussion
This study identiﬁed usability issues with a novel actionable e-A&F
system for primary care, regarding eﬃciency, errors, satisfaction, and
utility. The main strength was to use a multi-method approach to
evaluate all four e-A&F interface components (clinical performance
summaries, patient lists, detailed patient-level data, and suggested ac-
tions) to enhance, explain, triangulate and increase completeness of ﬁnd-
ings [10]. The main limitation was that the team who developed the
system also performed the evaluation.
In the following discussion we combine our ﬁndings with wider
usability literature in order to reﬁne a previously published set of
preliminary interface design recommendations for e-A&F systems [3]
(Box 3). We also discuss the implications of these ﬁndings for patient
safety by drawing on emerging results from an ongoing systematic
meta-synthesis of qualitative research studies of A&F performed by our
research group [15]. Finally, we discuss the limitations of our research
methodology in more detail.
4.1. Reﬁned interface design recommendations for e-A&F systems
4.1.1. Clinical performance summaries
Clinical performance summaries should cover multiple clinical to-
pics relevant to users. Where possible they should address issues of
over-treatment, missed diagnoses, and inappropriate treatment (e.g. in
patients receiving palliative care). To align with users’ workﬂows they
should oﬀer functionality to include quality indicators addressed by
existing quality programmes (e.g. [38,39] in PINGR’s case), and for
users to select those in which they are most interested. Where appro-
priate, clinical performance should be framed positively rather than
negatively (e.g. by presenting the number of patients attaining a quality
standard rather than the number not attaining). This is supported by
studies of presenting quantitative information to clinicians [77,78], and
may leverage principles of positive psychology by making users feel
recognised for their performance eﬀorts, creating a positive loop of
further action and interaction with the system [79].
Quality indicator results from all clinical domains should be pre-
sented concurrently in one display screen. This enhances information
processing by making data comparison eﬃcient, and is supported by
studies of health-related dashboards [80,81]. Data prioritisation can be
further helped through the presentation of clinical performance trends
over time, and by explicitly comparing users’ scores with desirable le-
vels of performance (targets/goals). Both elements should be presented
simultaneously to increase the likelihood of visualisation; the use of
space-saving tools such as sparklines [82] may help. Although users
may prefer peer performance data as the target/goal by which to judge
their performance (e.g. average peer performance), other options for
choosing targets/goals exist (e.g. set by experts, or based on past per-
formance). Systems may further reduce cognitive load by automatically
prioritising quality indicators on behalf of users and communicating
this via colour (e.g. RAG rating) or the order in which they are dis-
played [41]. Criteria for prioritisation may include current levels of
performance or predicted numbers of patient adverse outcomes
[47,51].
Like PINGR’s improvement opportunity charts, e-A&F systems
should routinely evolve their approaches to the analysis and visuali-
sation of clinical performance. This is supported by ﬁndings from
evaluations of other e-A&F systems [80,83], and may include patients
not achieving quality standards grouped according to similar actions (as
in PINGR), or other patient/organisation variables. Where possible,
these visualisations should highlight relevant patients for action via the
patient list interface component. To facilitate cognitive processing,
analyses should be displayed concurrently with overall quality in-
dicator results, and provide a limited number of ﬁndings (e.g. by fo-
cusing on the largest groups of patients). They should include clear
explanations of their methods and results, with instructions regarding
how they may help action planning. Such detailed instructions have
been found necessary in similar population-level data exploration tools
[84].
4.1.2. Patient lists
Patient lists should present suﬃcient information to enable users to
eﬃciently prioritise patients for action or review, which may include:
age; physiological measures relevant to the quality indicator; number of
relevant improvement opportunities; whether a particularly high-risk
quality indicator is violated (e.g. untreated high-risk AF); and where
relevant, their predicted risk of an adverse outcome (e.g. cardiovascular
disease event). Given the many variables that could be included in
patient lists, and variation in user preference demonstrated in our
study, it may be appropriate for users to maintain freedom and control
by customising which are displayed [35]. The ability to order and ﬁlter
patient lists is essential for prioritisation, and the availability of this
function should be made clear. User control over patient list variables
and ordering is supported by wider EHR design guidelines [85]. To
avoid the volume of patients in lists overwhelming users, e-A&F systems
may display a manageable number at any one time (e.g. 10) starting
with the highest priority, and further displayed on demand. This con-
ﬂicts with EHR design guidelines that state all patients in a list must be
visible on one page to ensure they are not missed [85], though is ac-
ceptable because e-A&F systems are not intended for direct patient care
(unlike EHRs) [2]. Icons used in patient lists should be appropriate to
the clinical context in which they are used. For example, radiological
systems should avoid using red dot icons, which are also used to
highlight abnormal ﬁndings on a radiological image [86]. This agrees
with more general icon usability guidelines regarding [87], though may
only be recognised as problematic through user testing.
4.1.3. Detailed patient-level information
Detailed patient-level information should be accessible via inter-
active links to drill-down from population-level aggregated data [22]. It
should be comprehensive enough to provide users with suﬃcient
B. Brown et al. Journal of Biomedical Informatics 77 (2018) 62–80
73
Box 2
Summary of NPT-driven SWOT analysis interviews related to PINGR’s utility.
Strengths
Clinical performance summaries
• Covers multiple clinical areas and quality indicators relevant to primary care.
• Includes quality indicators relating to undiagnosed patients, over-treated patients (e.g. over-anticoagulation in AF), and patients who may
beneﬁt from exclusion (e.g. palliative care patients), thus addressing issues of over-medicalisation often ignored by e-A&F systems.
• Improvement opportunity chart provides unique insights into reasons for poor performance, guides improvement action, and saves time by
ﬁltering patient lists to those requiring the similar actions.
Patient lists
• Lists patients requiring action to facilitate quality improvement.
Suggested actions
• Shifts focus from data interpretation to improvement action not seen in other e-A&F systems.
• Saves time by negating the need for users to formulate their own action plans.
• Functionality to save, download and mark actions as implemented helps manage workﬂow, enables communication with other staﬀ, and can
be used as evidence for annual appraisals.
• Links to case reports (organisation-level) and patient information leaﬂets (patient-level) aids implementation.
• User-added actions share best practice between organisations.
Detailed patient-level information
• Ability to drill-down from population-level to patient-level data via interactive links is intuitive and user-friendly.
• Provides non-clinical data (e.g. patient contacts with primary care practice/oﬃce) alongside clinical data (e.g. historic blood pressure
measurements), which contextualises how to implement improvement action (e.g. how to contact a patient to measure their blood pressure
if necessary).
Weaknesses
Clinical performance summaries
• Inclusion of quality indicators with diﬀering guidance is confusing (e.g. diﬀerent blood pressure targets [38,39]).
• Unclear how to use improvement opportunity chart to ﬁlter patient list.
• Improvement opportunity chart sometimes contained too many categories and unclear explanations to be eﬃciently interpreted.
Opportunities
Clinical performance summaries
• Addition of quality indicators in areas important to primary care (e.g. chronic obstructive pulmonary disease, diabetes, and general health
checks).
• Tailoring of quality indicators displayed based on user-preference.
Detailed patient-level information
• Inclusion of: demographics; medication adherence or prescription frequency; historical medication prescriptions with dates and reasons for
cessation; relevant improvement opportunity categories; and additional physiological parameters and comorbidities.
Suggested actions
• Integration with existing information systems, including: ability to open patients’ EHRs and vice versa; write-in functionality to EHRs; direct
communication with patients via text messages/letters/emails; and medication prescribing.
• Ability to view other users’ agreed actions within their organisation to aid action planning and prevent work duplication.
• Inclusion of patient decision aids where appropriate (e.g. regarding recommended treatments).
• Alignment with local clinical pathways.
• Link organisation-level suggested actions to speciﬁc reasons for suboptimal performance.
• Present those not previously considered by users.
• Patient-level actions may be valuable for nurses conducting chronic disease clinics.
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Threats
Detailed patient-level information
• Should not aim to be comprehensive because users:
o only wish to view data relevant to quality indicators;
o may believe they are viewing the full EHR, which may lead to safety issues (e.g. if all currently prescribed medications or laboratory tests
are not displayed).
Suggested actions
• Some users may formulate their own actions and ignore them.
AF = Atrial ﬁbrillation; e-A&F = electronic audit and feedback; EHR = Electronic health record.
Box 3
Summary of interface design recommendations for electronic audit and feedback systems, and questions for further research, reﬁned from
[3].
Clinical performance summaries, should:
• Cover multiple clinical topics relevant to users.
• Address over-treatment, missed diagnoses, and situations where it may be inappropriate to treat patients (e.g. when receiving palliative
care).
• Allow users to select which quality indicators to display.
• Be framed positively where appropriate to emphasise achievement (e.g. patients achieving a quality standard, rather than those not
achieving).
• Be presented across all clinical topics concurrently in one display screen.
• Use line graphs to demonstrate trends over time with tooltips to interpret historic performance data.
• Compare users’ scores to desirable levels of performance (targets/goals).
• Automatically prioritise quality indicators (e.g. through the use of colour or ordering).
• Undertake further data analysis and visualisation related to improvement action.
• Explain clearly to what performance data speciﬁcally refer.
Patient lists, should:
• Present suﬃcient information to eﬃciently prioritise patients (e.g. age, physiological measures, number of quality indicators violated).
• Allow users to control what information is used to prioritise patients.
• Clearly allow users to order and ﬁlter patients.
• Display a limited number of high-priority patients (e.g. 10), with more on-demand.
• Use appropriate icons to communicate patient variables.
• Explain clearly to what they refer.
Detailed patient-level information, should:
• Be accessible via interactive links to drill-down from population-level data.
• Be comprehensive enough to provide users with suﬃcient information to interpret suggested actions, and formulate their own.
• As a minimum include demographics, diagnoses, physiological measures, and prescribed medications.
• Include both clinical and non-clinical data (e.g. contacts with the primary care practice/oﬃce).
• Only include information directly relevant to taking improvement action.
• Use line charts to display physiological data with tooltips to interpret historic performance data.
• Provide users the option to display data as tables.
• Be displayed on a single page.
• Be completely separate from other interface components.
• Provide a warning the system is not attempting to replicate a patient’s health record.
• Enable users to highlight inconsistencies with health record data.
Suggested actions, should:
• Address both the individual patient and organisation.
• Be derived from acceptable sources (e.g. clinical guidelines or the wider quality improvement literature).
• Align with local clinical pathways.
• Address speciﬁc reasons for users’ poor performance based on detailed analysis of clinical performance data.
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information to: interpret suggested actions; formulate their own; and
avoid ineﬃciencies of accessing other information sources (e.g. EHRs).
Similar recommendations have been made with primary care popula-
tion-level data exploration tools [88]. As a minimum, patient-level in-
formation should include: demographics; diagnoses; physiological
measures; and current and past medications (including data on ad-
herence and reasons for stopping medications). Both clinical (e.g.
physiological measurements, medication prescriptions) and non-clin-
ical (e.g. contacts with the primary care practice/oﬃce) data should be
displayed to illustrate how patients interact with the health system,
which can in turn facilitate action. However, only data directly relevant
to taking action should be presented in order to aid information
prioritisation. Line charts should be used to display patients’ physio-
logical data where possible to facilitate interpretation and prioritisa-
tion. This is supported by evaluations of patient-level dashboards [80],
and graphical representations of patient-reported outcome measures
(PROMs) [89]. To accommodate user control and freedom [35],
maintain appropriate representational formats [27], and aid inter-
pretation [33], users should have the option to also display data as
tables. This is supported by EHR design guidelines [90], and studies of
PROM [91] and laboratory data [92]. To facilitate perceptual grouping
and relationships between data [27], patient-level information should
be displayed on a single page. This in turn helps prioritise which clinical
areas require most urgent attention, and reduce cognitive overload
[26]. Visualisation techniques may help by eﬃciently summarising
patient-level information [93]; LifeLines display data as multiple charts
over a common timeline [94]. To provide visually distinct screens for
confusable items [27], detailed patient-level information should be
completely separate from other interface components. Although this
may counter-intuitively interfere with anticipated workﬂows, it is
supported by EHR design guidelines [85]. There should be a warning
that the system does not replicate patients’ entire EHRs to avoid false
impressions of its completeness and reduce the risk of patient safety
events (e.g. a limited medication list may risk drug-drug interactions if
new ones are prescribed). Users should have the ability to validate the
accuracy of patient-level information, though to ﬁt their workﬂow only
highlighting inconsistencies should be necessary [27].
4.1.4. Suggested actions
Suggested actions may be derived from clinical guidelines, and the
wider quality improvement literature. They should align with local
clinical pathways, and address speciﬁc reasons for users’ under-per-
formance based on detailed analysis of their patients’ EHR data [48,49].
Suggestions should strive to present ideas users have previously con-
sidered, and where possible adapt to contextual features of organisa-
tions (e.g. whether they have already been implemented) and in-
dividual patients (e.g. clinical contraindications) [51]. This mirrors CDS
design guidelines that specify patient-level alerts should incorporate
relevant data into decision logic to improve speciﬁcity [51]. Suggested
actions should: be written concisely (e.g. using bullet points); provide
further detail on-demand regarding why it was suggested (i.e. algo-
rithm logic) [51,56]; report how other organisations achieved change
(case reports); and include patient-facing information (e.g. information
leaﬂets or decision aids). They should account for the ﬁrst step a user
may take during implementation such as consulting a patient or dis-
cussing a potential organisational change with colleagues. This could be
achieved through: the phrasing of the suggested action text (e.g. using
goal-setting theory [95]); encouraging users to add their own actions to
• Adapt to contextual features of organisations (e.g. whether or not actions have already been implemented) and individual patients (e.g.
potential contraindications).
• Strive to present ideas users have not previously considered.
• Be written concisely (e.g. using bullet points).
• Provide details on-demand regarding why they were suggested, how they have been implemented in other organisations (case reports), and
patient-facing information (e.g. information leaﬂets).
• Address the ﬁrst step a user may take during implementation.
• Be located in a separate interface component aligned with user workﬂow (e.g. on the same screen as clinical performance summaries, or
detailed patient-level information).
• Display only the most important three or four options concurrently, though provide the option to view more if desired.
• Be prioritised according to patient safety, potential eﬀectiveness, ﬁnancial value, or ‘quick wins’, which should be accommodated through
user settings where possible.
• Have their prioritisation communicated through the order in which they are displayed or their colour.
• Be advisory, allowing users to indicate disagreements (using both ﬁxed and free-text responses).
• Use data from user disagreements to improve their algorithms.
• Allow users to add their own actions, which should be saved automatically, and used to optimise the system’s own suggestions.
• Allow users to clearly save, mark them implemented, and view those of other users within their organisation.
• Provide functionality to view, undo and edit previous disagreement reasons.
• Allow users to order and manually prioritise saved actions, set deadlines and reminders, assign them to users, and export for wider sharing.
• Have clear response options, and ideally automatically detect when an action has been implemented.
• Provide functionality to easily action the recommendation, which may be facilitated through integration with existing health information
systems (e.g. write-in functionality to health records or direct patient communication via text message).
Questions for further research:
• How much interface adaptation should be user-controlled or automated?
• What methods can optimise automated interface adaptation?
• What methods are most appropriate to adapt suggested actions to contextual features of organisations and patients?
• Which are the most eﬀective types of targets/goals to use in clinical performance summaries?
• What additional methods for deriving suggested actions are possible, acceptable, eﬃcient, and eﬀective?
• What are the most appropriate criteria and methods to prioritise clinical performance summaries, patient lists, and suggested actions?
• What are the optimal ways to communicate and display this prioritisation?
• What is the optimal position of suggested actions within the user interface?
• How do ﬁndings from this study translate to more naturalistic settings outside the laboratory?
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reﬂect this workﬂow; or providing an option to defer their decision
about an action [52,96]. Suggested actions should be displayed to align
with user workﬂow, which may be inﬂuenced by whether they are
presented on the left or right of the page [82,97]. They should be
prioritised, displaying only the most important three or four options
across all quality indicators concurrently, with the option to view more
if desired. Preferred prioritisation criteria may vary between users, and
should be accommodated with user preference settings where possible.
Examples may include: patient safety issues [47,51]; potential eﬀec-
tiveness; ﬁnancial value; and quick wins. Prioritisation may be com-
municated through action ordering or colour [27]. To improve accep-
tance, they should be presented as advisory [51,57], and allow users to
indicate disagreement (which in turn should be captured and used to
improve systems’ algorithms [47,51]). This may be re-enforced by a
warning that suggestions do not over-rule clinical judgment. Users
should be able to add their own actions, which should be saved auto-
matically [27], in addition to being used to optimise systems’ own
suggestions. Users should be able to save suggested actions, mark them
implemented, and view other users’ actions to facilitate intra-organi-
sational teamwork. Saved actions should be displayed at the end of the
navigation menu to align with user workﬂows [47]. It should be pos-
sible to order and manually prioritise saved actions, with the facility to
set deadlines and reminders, assign them to colleagues, and export
them for wider sharing. Response options to suggested actions should
be clear [27], and to reduce cognitive load e-A&F systems should au-
tomatically detect when an action has been implemented. Where pos-
sible, e-A&F systems should facilitate action implementation, which
may be helped by integration with existing health information systems
[51] such as EHR write-in functionality or direct communication with
patients via text message.
4.2. Implications for patient safety
Considering our design recommendations (Box 3) in the wider
context of A&F causal pathways [15], we can frame their implications
on patient safety through three main concepts: user engagement, ac-
tionability, and information prioritisation.
User engagement may be inﬂuenced through system compatibility,
relative advantage, and satisfaction. Compatibility may refer to: the
clinical areas addressed by the system; existing systems, policies and
workﬂows with which they align; and user preferences. Ensuring e-A&F
systems address clinical areas users deem important and relevant, and
that align with existing quality or ﬁnancial incentive programmes, is
essential to ensuring compatibility with their goals and motivation
[98]. Similarly, e-A&F systems should align with user workﬂows, and
integrate with existing information systems. Compatibility with user
preferences can be improved by enabling user-controlled customisation
and tailoring [26,35]. Incompatible e-A&F systems may not be used by
health professionals [99]) or may be dismissed as trivial [100]. PINGR’s
relative advantages relate to its provision of detailed patient-level in-
formation, suggested actions, and user-friendliness. Ways in which
other e-A&F systems can provide relative advantages depends on the
individual system and environment into which it is implemented [21].
If a system has a perceived relative advantage, it is more likely to be
used and implemented [98]. User satisfaction with e-A&F systems can
be inﬂuenced by its eﬃciency and tendency to induce user errors [101].
e-A&F that are more satisfying and positive to use encourage further
engagement [102]. Where there is non-engagement with an e-A&F
system – whether due to incompatibility, relative disadvantage, or
dissatisfaction – potentially important clinical performance information
is ignored, which could lead to failures in patient safety (e.g. [6]),
whereas continued engagement generally leads to improved patient
care [2].
Users must take action based on the information from e-A&F sys-
tems in order for improvements in patient care and safety to take place
[37]. However, health professionals often do not have the time or skills
to translate clinical performance information into improvement action
[40]. Therefore maximising the actionability of e-A&F increases this
likelihood [2]. Our design recommendations suggest this can be
achieved by providing: additional clinical performance data analysis
and visualisations; suggested actions; patient lists; and detailed patient-
level data. Clinical performance data analyses (such as the improve-
ment opportunities charts in PINGR) can help users understand po-
tential reasons for low performance, and identify groups of patients
requiring similar actions [102]. Suggested actions can help users for-
mulate plans for improvement [103]. This is especially true for orga-
nisation-level actions, which may have the greatest eﬀect on patient
care but clinicians often struggle with most [40,101]. Optimising sug-
gested action algorithms through user feedback shares best practice
between organisations [103] and harnesses positive deviance [104].
Patient lists and detailed patient-level data direct the user’s attention to
patients requiring action or further investigation [43]. Not providing
patient lists makes it diﬃcult for users to understand who to target or
how to improve [40]. Similarly, an absence of detailed patient-level
information may mean users fail to take action [101].
Our design recommendations highlight the importance of informa-
tion prioritisation in all key e-A&F interface components. Health pro-
fessionals have limited time to dedicate to quality improvement due to
competing clinical and non-clinical responsibilities [40,105]. If their
attention is not directed to the most important feedback information,
the most appropriate improvement action will likely not occur [19]. For
example: focusing on a quality indicator that is not the worst per-
forming may not result in improvement action or the greatest popula-
tion health gain [106]; reviewing a patient violating multiple quality
standards would be more eﬀective than one that violates only one [40];
being unable to view the most important areas of a patient’s informa-
tion may miss additional, more important areas requiring attention
[101]; and implementing an evidence-based action may be more ef-
fective than one that is not [98]. An additional beneﬁt of information
prioritisation is that it prevents users feeling overwhelmed and dis-
illusioned by the amount of work they perceive needs to be undertaken.
Similar to alert fatigue [107], if this happens users may reject the e-A&F
system or abandon improvement work altogether [19]. Nevertheless,
prioritisation techniques should be used with caution as they may have
unintended consequences: for example, using average peer performance
as a target may not comprehensively raise standards, as by deﬁnition
around half the group will already have achieved it.
4.3. Study limitations
The team who designed and built the system conducted this eva-
luation, the lead investigator of which held a position recognisable to
study participants as a primary care physician. This posed risks to: the
trustworthiness of our ﬁndings including how participants behaved
[65]; our interpretation of this behaviour [70]; and our degree of po-
sitivity in communicating our results [71]. We took speciﬁc steps to
address these potential problems (Section 2.5 above), and in doing so
believe we present a balanced and detailed critique of PINGR. On re-
ﬂection, author BB found his position may have aﬀorded him insider
status [108], gaining more honest insights from participants than a non-
medically qualiﬁed researcher could elicit. The study’s small sample
size (n=7 participants) may be perceived as a further weakness,
though was guided by the achievement of thematic saturation of us-
ability issues [61]. This implies the cost of including further partici-
pants would have been unnecessary [59,60]. Interview transcripts were
coded by one researcher, which may be viewed as a threat to credibility
[109]. However, we took explicit steps to mitigate this by triangulating
ﬁndings from multiple data sources [110], in addition to holding cri-
tical analytic discussions between authors to challenge any potential
biases or assumptions [72]. Our interface design recommendations for
e-A&F systems (Box 3) have been derived from empirical studies of one
system (PINGR). Although PINGR’s design has been informed by
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relevant existing usability [3] and theoretical [15,16] evidence, and its
evaluations contextualised in the wider usability literature, eﬀective
alternative e-A&F designs may exist. Given the paucity of evidence on e-
A&F usability, our recommendations are a reasonable starting point,
though should continue to be tested and reﬁned in future. Finally, given
this study focused on interface usability in a controlled laboratory
setting, it does not address issues that may only be revealed when e-
A&F systems are studied in more naturalistic settings [5]. Examples
include problems with system implementation, such as how work
arising from e-A&F is distributed between health professionals [101], in
addition to wider cultural issues, such as whether clinicians are com-
fortable with scrutiny of their performance by a machine [111].
5. Conclusions
We used a combination of qualitative and quantitative methods to
evaluate the usability of a novel e-A&F system with target end-users. In
doing so, we gained important insights into how to design user-friendly
e-A&F systems according to their four key interface components (clin-
ical performance summaries, patient lists, detailed patient-level in-
formation, and suggested actions), and how they can be integrated. This
enabled us to reﬁne key design recommendations (Box 3) [3], and
determine their implications for patient safety. Although our study fo-
cused on primary care and long-term conditions, our ﬁndings may
generalise to other clinical areas and settings.
Each of our data sources (user observation, questionnaires, and in-
terviews) uncovered novel usability issues as well as providing further
understanding of those reported by others [10]. Methodologically, we
showed how to maximise the discovery of usability issues in a complex
health information system [11], and increase the validity of our ﬁnd-
ings [110,72]. As far as we are aware, this is the ﬁrst published study of
an e-A&F system to use eye tracking, and therefore presents unique
insights into visual search behaviour, integrated within a wider data
set.
We report answers to previously identiﬁed research questions for e-
A&F system design [3], on how to: display information in patient lists;
summarise patient-level data across multiple clinical areas; and whe-
ther to incorporate clinical performance of other users. This study raises
further questions (Box 3); notably how best to prioritise and commu-
nicate clinical performance summaries, patient lists, and suggested
actions – a grand challenge of CDS [29] – and how these ﬁndings
translate to more naturalistic settings. Future work will seek to address
these questions in further phases of our iterative development frame-
work [5]. Finally, our ﬁndings provide further support for, and an ex-
ample of, multi-method approaches in usability studies [12,13].
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